文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Single tumor-initiating cells evade immune clearance by recruiting type II macrophages.

作者信息

Guo Xiaocan, Zhao Yang, Yan Huan, Yang Yingcheng, Shen Shuying, Dai Xiaoming, Ji Xinyan, Ji Fubo, Gong Xing-Guo, Li Li, Bai Xueli, Feng Xin-Hua, Liang Tingbo, Ji Junfang, Chen Lei, Wang Hongyang, Zhao Bin

机构信息

Life Sciences Institute, Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou, Zhejiang 310058, China.

International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, China.

出版信息

Genes Dev. 2017 Feb 1;31(3):247-259. doi: 10.1101/gad.294348.116. Epub 2017 Feb 21.


DOI:10.1101/gad.294348.116
PMID:28223311
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5358722/
Abstract

Tumor infiltrated type II (M2) macrophages promote tumorigenesis by suppressing immune clearance, promoting proliferation, and stimulating angiogenesis. Interestingly, macrophages were also found to enrich in small foci of altered hepatocytes containing liver tumor-initiating cells (TICs). However, whether and how TICs specifically recruit macrophages and the function of these macrophages in tumor initiation remain unknown due to technical difficulties. In this study, by generating genetically defined liver TICs, we demonstrate that TICs actively recruit M2 macrophages from as early as the single-cell stage. Elimination of TIC-associated macrophages (TICAMs) abolishes tumorigenesis in a manner dependent on the immune system. Mechanistically, activation of the Hippo pathway effector Yes-associated protein (YAP) underlies macrophage recruitment by TICs. These results demonstrate for the first time that macrophages play a decisive role in the survival of single TICs in vivo and provide a proof of principle for TIC elimination by targeting YAP or M2 macrophages.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17d/5358722/709b3193addc/247f07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17d/5358722/05a9766ac615/247f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17d/5358722/4d9e2daedb8f/247f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17d/5358722/cb91cfa7f333/247f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17d/5358722/18056649bd95/247f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17d/5358722/1f1a459a053d/247f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17d/5358722/0c9e3cae2e11/247f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17d/5358722/709b3193addc/247f07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17d/5358722/05a9766ac615/247f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17d/5358722/4d9e2daedb8f/247f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17d/5358722/cb91cfa7f333/247f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17d/5358722/18056649bd95/247f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17d/5358722/1f1a459a053d/247f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17d/5358722/0c9e3cae2e11/247f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17d/5358722/709b3193addc/247f07.jpg

相似文献

[1]
Single tumor-initiating cells evade immune clearance by recruiting type II macrophages.

Genes Dev. 2017-2-1

[2]
High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis.

Hepatology. 2018-4-1

[3]
YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma.

Sci Rep. 2016-9-8

[4]
Bile acids activate YAP to promote liver carcinogenesis.

Cell Rep. 2013-11-21

[5]
Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.

Oncotarget. 2016-4-12

[6]
Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis.

J Clin Invest. 2017-1-3

[7]
Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer.

Hepatology. 2013-7-16

[8]
Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis.

Nat Commun. 2015-2-19

[9]
YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis.

Cancer Res. 2020-12-15

[10]
Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma.

Gut. 2017-9-2

引用本文的文献

[1]
Impact of exercise on immune cell infiltration in muscle tissue: implications for muscle repair and chronic disease.

Clin Exp Med. 2025-8-27

[2]
Nucleus-translocated glucokinase functions as a protein kinase to phosphorylate TAZ and promote tumour growth.

Nat Commun. 2025-8-4

[3]
Multiple signaling pathways in the frontiers of lung cancer progression.

Front Immunol. 2025-6-10

[4]
Exosomes in bridging macrophage-fibroblast polarity and cancer stemness.

Med Oncol. 2025-5-21

[5]
Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy.

J Exp Clin Cancer Res. 2025-5-16

[6]
The Importance of Cancer Stem Cells and Their Pathways in Endometrial Cancer: A Narrative Review.

Cells. 2025-4-14

[7]
The mechanism of YAP/TAZ transactivation and dual targeting for cancer therapy.

Nat Commun. 2025-4-24

[8]
Disrupting bile acid metabolism by suppressing Fxr causes hepatocellular carcinoma induced by YAP activation.

Nat Commun. 2025-4-15

[9]
Hippo Signaling Is Essential for the Maintenance of Zona Glomerulosa Cell Fate in the Murine Adrenal Cortex.

Endocrinology. 2025-4-22

[10]
A study of the association between infection type and pancreatic cancer risk: A systematic review and meta‑analysis.

Oncol Lett. 2025-2-7

本文引用的文献

[1]
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression.

Cancer Cell. 2016-10-10

[2]
Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.

Hepatology. 2016-11

[3]
LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development.

Nat Commun. 2016-6-30

[4]
Mechanisms of Cytotoxic Lymphocyte-Mediated Apoptosis and Relationship with the Tumor Suppressor p53.

Crit Rev Immunol. 2015

[5]
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.

Cancer Discov. 2016-1

[6]
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.

Cell. 2015-11-5

[7]
YAP and TAZ Take Center Stage in Cancer.

Biochemistry. 2015-11-3

[8]
YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers.

Mol Cell. 2015-10-15

[9]
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth.

Nat Cell Biol. 2015-9

[10]
Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer.

J Hepatol. 2015-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索